Spontaneous Regression of an HIV-Associated Plasmablastic Lymphoma in the Oral Cavity: A Case Report

Journal of Oral and Maxillofacial Surgery

Volumn 65, Issue 7, 2007, Pages 1361-1364

  Armstrong, Robert ^a   Bradrick, Jon ^b   Liu, Yao Chang ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; RITONAVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEFENSE MECHANISM; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LABORATORY TEST; LYMPHOMA; MALE; MOUTH CAVITY; RADIODIAGNOSIS;

ADULT; ANTIGENS, CD79; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MAXILLARY NEOPLASMS; NEOPLASM REGRESSION, SPONTANEOUS; SYNDECAN-1;

EID: 34250201452     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2005.12.039     Document Type: Article

References (14)

1. Cioc A.M., Allen C., Kalmar J.R., et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28 (2004) 41
2. Delecluse H.J., Anagnostopoulos F., Dallenbach M., et al. Plasmablastic lymphomas of the oral cavit: A new entity associated with the human immunodeficiency virus infection. Blood 89 (1997) 1413
3. Lester R. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: A report of two cases. Leuk Lymphoma 45 (2004) 1881
4. Kumar V., Robbins S., and Cotran R. Pathologic Basis of Disease. Ed 7 (2005), Elsevier, Philadelphia, PA
5. Jaffe E., Harris N., Stein H., et al. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon
6. Flaitz C.M., Nichols C.M., Walling D.M., et al. Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations. Oral Oncology 38 (2002) 96
7. Collazos J., Ojanguren J., Mayo J., et al. Lymphoma developing shortly after the onset of highly active antiretroviral therapy in HIV-infected patients. AIDS 16 (2002) 1304
8. Nasta S.D., Carrum G.M., Shahab I., et al. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 43 (2002) 423
9. Brown R.S.D., Power D.A., Spittle H.F., et al. Absence of immunohistochemical evidence for Human Herpesvirus 8 in oral cavity plasmablastic lymphoma in HIV-positive man. Clin Oncology 12 (2000) 194
10. Gustaffson E.A., Schriazi R.F., and Fingeroth J.D. Human Herpesvirus 8 Open Reading Frame 21 is a thymidine and thymidilate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J Virol 74 (2000) 684
11. Chetty R., Hlatswayo N., Muc R., et al. Plamablastic lymphoma in HIV+ patients: An expanding spectrum. Histopathology 42 (2003) 605
12. Nador R., Chadburn A., Gundappa G., et al. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 27 (2003) 293
13. Nalesnik M.A., Jaffe R., Starzi T.E., et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133 (1988) 173
14. Knowles D.M., Cesarmen E., Chadburn A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85 (1995) 552